Download PDF
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Sofosbuvir-based regimens for HCV in stage 4–stage 5 chronic kidney disease. A systematic review with meta-analysis
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Ezequiel Ridruejo
10.1016/j.nefroe.2021.11.011
Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease
Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi
10.1016/j.nefroe.2019.03.014
The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa
10.1016/j.nefroe.2020.06.005